SEC Form 4 · accession 0001179110-18-009630
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa N Colleran
Director
Period of report
Jul 9, 2018
Accepted (ET)
Jul 11, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $53.65 | Jul 9, 2018 | A | 9,134 | A | — | Jul 9, 2028 | Common Stock | 9,134 | 9,134 | D |
| Stock Option (right to purchase)F2 | $53.65 | Jul 9, 2018 | A | 3,916 | A | — | Jul 9, 2028 | Common Stock | 3,916 | 3,916 | D |
Explanation of responses
- F1Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on October 9, 2018 and becoming fully vested July 9, 2020 (two years after grant).
- F2Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period. Option vests quarterly with all shares vested June 1, 2019 in conformity with vesting for such annual director grants.